Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 798912, 13 pages
Research Article

Identifying Breast Cancer Subtype Related miRNAs from Two Constructed miRNAs Interaction Networks in Silico Method

Biomedical Engineering Institute of Capital Medical University, Beijing 100069, China

Received 13 July 2013; Revised 29 September 2013; Accepted 4 October 2013

Academic Editor: Qinghua Cui

Copyright © 2013 Lin Hua et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. It has been known that microRNAs (miRNAs) regulate the expression of multiple proteins and therefore are likely to emerge as more effective targets of selective therapeutic modalities for breast cancer. Although recent lines of evidence have approved that miRNAs are associated with the most common molecular breast cancer subtypes, the studies to breast cancer subtypes have not been well characterized. Objectives. In this study, we propose a silico method to identify breast cancer subtype related miRNAs based on two constructed miRNAs interaction networks using miRNA-mRNA dual expression profiling data arising from the same samples. Methods. Firstly, we used a new mutual information estimation method to construct two miRNAs interaction networks based on miRNA-mRNA dual expression profiling data. Secondly, we compared and analyzed the topological properties of these two networks. Finally, miRNAs showing the outstanding topological properties in both of the two networks were identified. Results. Further functional analysis and literature evidence confirm that the identified potential breast cancer subtype related miRNAs are essential to unraveling their biological function. Conclusions. This study provides a new silico method to predict candidate miRNAs of breast cancer subtype from a system biology level and can help exploit for functional studies of important breast cancer subtype related miRNAs.